7th International Multidisciplinary Good Medical Research Digital Congress..

  • 9/10/2020

The Congress will be held on 24 October 2020 by MedicRes.

Read More…

FDA Finalizes Enforcement Procedure for ClinicalTrials.gov Reporting Requirements...

  • 8/17/2020

To ensure transparency FAD updated ClinicalTrials.gov reporting requirements, issuing final guidance last week that confirms penalties of up to $10,000 per violation.

Read More…

Nature: Worries on Russian COVID-19 vaccine

  • 8/12/2020

Russia hasn’t completed large trials to test its safety and efficacy, and rolling out an inadequately vetted vaccine could put at risk people who receive it, researchers say. It could also impede global efforts to develop quality COVID-19 immunizations,

Read More…

Web of Science 2019 Impact Factor results..

  • 6/30/2020

Clarivate Analytics - Web of Science 2019 Impact Factor results have been announced on 29.06.2020. Turkish Journal of Hematology scored 1.685 and Turkish Journal of Gastroenterology scored 1.11

Read More…

Coronavirus vaccine tracker

  • 6/12/2020

There are more than 135 vaccine trials going on. The New York Times prepared a web site to monitor these trials.

Read More…

Turkish Medicine and Device Agency is now a full member of ICH...

  • 6/2/2020

Turkey was an observational member and now become a full member. We congratulate the Turkish Medicine and Device Agency in their efforts to be a part of this.

Read More…

FDA app for electronic informed consent...

  • 5/30/2020

FDA developed an app to obtain informed consent securely from patients for eligible clinical trials when face-to-face contact is not possible or practical due to COVID-19 control measures. The app is named "FDA COVID MyStudies Application".

Read More…

FDA announced "COVID 19: Developing Drugs and Biological Products for Treatment or Prevention Guidance for Industry"

  • 5/13/2020

This guidance is being issued to address the Coronavirus Disease 2019 (COVID-19) public health emergency. This guidance is being implemented without prior public comment

Read More…

EMA updated the COVID-19 Guideline..

  • 4/30/2020

EMA updated Guidance on the Management of Clinical Trials During the COVID-19 (CORONAVIRUS) Pandemic.

Read More…

First biosimilar study against COVID-19..

  • 4/29/2020

The biosimilar study is conducted comparing Ritonavir and Lopinavir combination (Kaletra) against biosimilar candidate Orvical. Kaletra was approved against HIV.

Read More…